

Cover Story
Free
An argument can be made that only a government research agency like NCI has the capacity to answer questions about monitoring pancreatic cysts—and how some of them turn malignant.
In Brief


Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for Oct. 2021
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Betty Ford and the press conference that changed oncology
- Whither ARPA-H? What can Biden’s agency do that cancer centers can’t?
- Pazdur at FDA-ASCO workshop: Failure to optimize the dose is akin to building a house on quicksand
- FDA’s Lola Fashoyin-Aje: It’s time to increase racial diversity in trials—here’s a draft guidance for how this can be done
- Robert Winn, Rebecca Miksad, Dana Rollison: We must use real-world data and lessons from COVID to improve care, equity in communities we serve
- Gynecology’s deadly surprise: Cancers are frequently missed prior to routine procedures